{
  "id": 26071,
  "title": "Karyopharm shares crater on second Phase 3 flop for Xpovio in endometrial cancer",
  "url": "https://urgent.news/2026/07/31/karyopharm-shares-crater-on-second-phase-3-flop-for-xpovio-in",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-31T10:42:02.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/karyopharm-shares-crater-on-second-phase-3-flop-for-xpovio-in-endometrial-cancer/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Karyopharm’s stock has plummeted after its second attempt to expand its blood cancer medicine Xpovio into endometrial cancer fell short. Late Thursday, the company reported that its latest trial, called XPORT-EC-042 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}